LifeVantage Co. (NASDAQ:LFVN) Shares Purchased by American Century Companies Inc.

American Century Companies Inc. grew its holdings in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) by 50.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 95,552 shares of the company's stock after buying an additional 32,055 shares during the period. American Century Companies Inc. owned 0.76% of LifeVantage worth $1,675,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its stake in LifeVantage by 43.9% during the fourth quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company's stock worth $1,300,000 after acquiring an additional 22,620 shares in the last quarter. Copeland Capital Management LLC purchased a new stake in LifeVantage during the 4th quarter valued at $65,000. Ritholtz Wealth Management increased its position in LifeVantage by 65.2% during the fourth quarter. Ritholtz Wealth Management now owns 47,348 shares of the company's stock valued at $830,000 after acquiring an additional 18,682 shares during the last quarter. Barclays PLC boosted its holdings in shares of LifeVantage by 38.2% in the third quarter. Barclays PLC now owns 41,966 shares of the company's stock worth $507,000 after buying an additional 11,608 shares during the last quarter. Finally, HighTower Advisors LLC bought a new stake in shares of LifeVantage during the 3rd quarter valued at $638,000. Hedge funds and other institutional investors own 35.32% of the company's stock.

LifeVantage Price Performance

Shares of LFVN stock traded up $0.29 during mid-day trading on Tuesday, hitting $14.54. The stock had a trading volume of 8,404 shares, compared to its average volume of 123,853. LifeVantage Co. has a 12-month low of $5.22 and a 12-month high of $27.38. The firm's 50-day moving average is $16.34 and its two-hundred day moving average is $16.29. The firm has a market capitalization of $182.49 million, a P/E ratio of 25.96 and a beta of 0.75.

LifeVantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.14 by $0.08. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were given a dividend of $0.04 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.16 annualized dividend and a yield of 1.10%. LifeVantage's dividend payout ratio (DPR) is presently 28.57%.

Insider Transactions at LifeVantage

In related news, Director Raymond B. Greer sold 8,000 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $20.15, for a total transaction of $161,200.00. Following the transaction, the director now directly owns 99,288 shares in the company, valued at $2,000,653.20. The trade was a 7.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 20.65% of the company's stock.

Analysts Set New Price Targets

Several analysts recently issued reports on LFVN shares. Lake Street Capital initiated coverage on LifeVantage in a research report on Thursday, December 19th. They set a "buy" rating and a $26.00 target price for the company. Craig Hallum started coverage on shares of LifeVantage in a report on Tuesday, January 14th. They set a "buy" rating and a $35.00 price target on the stock.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.